Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/27327
Title: Design, synthesis and neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease
Authors: Keri, Rangappa S. 
Quintanova, Catarina 
Marques, Sérgio M. 
Esteves, A. Raquel 
Cardoso, Sandra M. 
Santos, M. Amélia 
Keywords: Tacrine; Benzothiazole; Alzheimer’s disease; Acetylcholinesterase inhibitors; Anti-Aβ aggregation; Anti-neurodegeneratives
Issue Date: 1-Aug-2013
Publisher: Elsevier
Citation: Keri, Rangappa S. [et. al] - Design, synthesis and neuroprotective evaluation of novel tacrine–benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease. "Bioorganic & Medicinal Chemistry". ISSN 0968-0896. Vol. 21 Nº.15 (2013) p. 4559-4569
Serial title, monograph or event: Bioorganic & Medicinal Chemistry
Volume: 21
Issue: 15
Abstract: Alzheimer’s disease (AD) is a multifactorial disorder with several target proteins contributing to its etiology. In search for multifunctional anti-AD drug candidates, taking into account that the acetylcholinesterase (AChE) and beta-amyloid (Aβ) aggregation are particularly important targets for inhibition, the tacrine and benzothiazole (BTA) moieties were conjugated with suitable linkers in a novel series of hybrids. The designed compounds (7a–7e) were synthesized and in vitro as well as in ex vivo evaluated for their capacity for the inhibition of acetylcholinesterase (AChE) and Aβ self-induced aggregation, and also for the protection of neuronal cells death (SHSY-5Y cells, AD and MCI cybrids). All the tacrine–BTA hybrids displayed high in vitro activities, namely with IC50 values in the low micromolar to sub-micromolar concentration range towards the inhibition of AChE, and high percentages of inhibition of the self-induced Aβ aggregation. Among them, compound 7a, with the shortest linker, presented the best inhibitory activity of AChE (IC50 = 0.34 μM), while the highest activity as anti-Aβ42 self-aggregation, was evidenced for compound 7b (61.3%, at 50 μM. The docking studies demonstrated that all compounds are able to interact with both catalytic active site (CAS) and peripheral anionic site (PAS) of AChE. Our results show that compounds 7d and 7e improved cell viability in cells treated with Aβ42 peptide. Overall, these multi-targeted hybrid compounds appear as promising lead compounds for the treatment of Alzheimer’s disease.
URI: http://hdl.handle.net/10316/27327
ISSN: 0968-0896
DOI: 10.1016/j.bmc.2013.05.028
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole.pdf1.17 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

67
checked on Nov 8, 2019

WEB OF SCIENCETM
Citations

62
checked on Nov 7, 2019

Page view(s) 50

450
checked on Dec 10, 2019

Download(s) 10

1,114
checked on Dec 10, 2019

Google ScholarTM

Check

Altmetric

Dimensions


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.